<?xml version="1.0" encoding="UTF-8"?>
<p id="Par2175">
 <bold>Conclusions:</bold> There is only limited evidence from RCTs at present to support use of NHFO rather than conventional therapy for acute hypoxemic respiratory failure in adults, and further study of patients at risk of requiring invasive ventilation is needed.
</p>
